Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Intravenous (IV) Solution are intended to be administered to the patients which are deficient in nutrients or at the time of serious dehydration. These solutions are given to the patients whose fluid volume or body nutrients falls.
Many companies manufactures packaged intravenous fluids or products or compounds which can be mixed with sterile water to prepare a solution for intravenous administration. The market for intravenous solutions is growing swiftly.
The report details the trend, potential and market size of Intravenous (IV) Solution market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Intravenous (IV) Solutionmarket, defines the market attractiveness level of Intravenous (IV) Solution market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Intravenous (IV) Solution industry, describes the types of Intravenous (IV) Solution market, the applications of major players and the market size, and deeply analyzes the current situation of the global Intravenous (IV) Solution market and the development prospects and opportunities of Intravenous (IV) Solution industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Intravenous (IV) Solution market in Chapter 13.
By Player:
Fresenius Kabi
Terumo Medical Corporation
Grifols
Amanta Healthcare
B Braun Melsungen
ICU Medical
Baxter
By Type:
by Product Type
Total Parenteral Solution
Peripheral Parenteral Solution
by Nutritional Content
Amino Acid Solution
Carbohydrates
Vitamins & Minerals
Parenteral Lipid Emulsion
Others
By End-User:
Hospitals & Clinics
Ambulatory
Homecare
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Intravenous (IV) Solution Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Intravenous (IV) Solution Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Intravenous (IV) Solution Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Intravenous (IV) Solution Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Intravenous (IV) Solution Market Analysis and Outlook to 2022
-
7.1 Global Intravenous (IV) Solution Consumption (2017-2022)
-
7.2 United States Intravenous (IV) Solution Consumption (2017-2022)
-
7.3 Europe Intravenous (IV) Solution Consumption (2017-2022)
-
7.4 China Intravenous (IV) Solution Consumption (2017-2022)
-
7.5 Japan Intravenous (IV) Solution Consumption (2017-2022)
-
7.6 India Intravenous (IV) Solution Consumption (2017-2022)
-
7.7 South Korea Intravenous (IV) Solution Consumption (2017-2022)
8 Region and Country-wise Intravenous (IV) Solution Market Analysis and Outlook to 2028
-
8.1 Global Intravenous (IV) Solution Consumption Forecast (2022-2028)
-
8.2 United States Intravenous (IV) Solution Consumption Forecast (2022-2028)
-
8.3 Europe Intravenous (IV) Solution Consumption Forecast (2022-2028)
-
8.4 China Intravenous (IV) Solution Consumption Forecast (2022-2028)
-
8.5 Japan Intravenous (IV) Solution Consumption Forecast (2022-2028)
-
8.6 India Intravenous (IV) Solution Consumption Forecast (2022-2028)
-
8.7 South Korea Intravenous (IV) Solution Consumption Forecast (2022-2028)
9 Global Intravenous (IV) Solution Market Outlook by Types and Applications to 2022
-
9.1 Global Intravenous (IV) Solution Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global by Product Type Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Total Parenteral Solution Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Peripheral Parenteral Solution Consumption and Growth Rate (2017-2022)
-
9.1.4 Global by Nutritional Content Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Amino Acid Solution Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Carbohydrates Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Vitamins & Minerals Consumption and Growth Rate (2017-2022)
-
9.1.8 Global Parenteral Lipid Emulsion Consumption and Growth Rate (2017-2022)
-
9.1.9 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Intravenous (IV) Solution Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals & Clinics Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Ambulatory Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Homecare Consumption and Growth Rate (2017-2022)
10 Global Intravenous (IV) Solution Market Outlook by Types and Applications to 2028
-
10.1 Global Intravenous (IV) Solution Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global by Product Type Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Total Parenteral Solution Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Peripheral Parenteral Solution Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global by Nutritional Content Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Amino Acid Solution Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Carbohydrates Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Vitamins & Minerals Consumption Forecast and Growth Rate (2022-2028)
-
10.1.8 Global Parenteral Lipid Emulsion Consumption Forecast and Growth Rate (2022-2028)
-
10.1.9 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Intravenous (IV) Solution Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals & Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Ambulatory Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Homecare Consumption Forecast and Growth Rate (2022-2028)
11 Global Intravenous (IV) Solution Import and Export Analysis (Top 5 Countries)
-
11.1 Global Intravenous (IV) Solution Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Intravenous (IV) Solution Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Intravenous (IV) Solution Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Intravenous (IV) Solution Market Competitive Analysis
-
14.1 Fresenius Kabi
-
14.1.1 Fresenius Kabi Company Details
-
14.1.2 Fresenius Kabi Intravenous (IV) Solution Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Fresenius Kabi Intravenous (IV) Solution Product and Service
-
14.2 Terumo Medical Corporation
-
14.2.1 Terumo Medical Corporation Company Details
-
14.2.2 Terumo Medical Corporation Intravenous (IV) Solution Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Terumo Medical Corporation Intravenous (IV) Solution Product and Service
-
14.3 Grifols
-
14.3.1 Grifols Company Details
-
14.3.2 Grifols Intravenous (IV) Solution Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Grifols Intravenous (IV) Solution Product and Service
-
14.4 Amanta Healthcare
-
14.4.1 Amanta Healthcare Company Details
-
14.4.2 Amanta Healthcare Intravenous (IV) Solution Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Amanta Healthcare Intravenous (IV) Solution Product and Service
-
14.5 B Braun Melsungen
-
14.5.1 B Braun Melsungen Company Details
-
14.5.2 B Braun Melsungen Intravenous (IV) Solution Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 B Braun Melsungen Intravenous (IV) Solution Product and Service
-
14.6 ICU Medical
-
14.6.1 ICU Medical Company Details
-
14.6.2 ICU Medical Intravenous (IV) Solution Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 ICU Medical Intravenous (IV) Solution Product and Service
-
14.7 Baxter
-
14.7.1 Baxter Company Details
-
14.7.2 Baxter Intravenous (IV) Solution Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Baxter Intravenous (IV) Solution Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Intravenous (IV) Solution
-
Figure Intravenous (IV) Solution Picture
-
Table Global Intravenous (IV) Solution Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Intravenous (IV) Solution Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Intravenous (IV) Solution Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Intravenous (IV) Solution Consumption by Country (2017-2022)
-
Figure United States Intravenous (IV) Solution Consumption and Growth Rate (2017-2022)
-
Table Europe Intravenous (IV) Solution Consumption and Growth Rate (2017-2022)
-
Figure China Intravenous (IV) Solution Consumption and Growth Rate (2017-2022)
-
Figure Japan Intravenous (IV) Solution Consumption and Growth Rate (2017-2022)
-
Figure India Intravenous (IV) Solution Consumption and Growth Rate (2017-2022)
-
Figure South Korea Intravenous (IV) Solution Consumption and Growth Rate (2017-2022)
-
Figure Global Intravenous (IV) Solution Consumption Forecast by Country (2022-2028)
-
Figure United States Intravenous (IV) Solution Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Intravenous (IV) Solution Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Intravenous (IV) Solution Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Intravenous (IV) Solution Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Intravenous (IV) Solution Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Intravenous (IV) Solution Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global by Product Type Consumption and Growth Rate (2017-2022)
-
Figure Global Total Parenteral Solution Consumption and Growth Rate (2017-2022)
-
Figure Global Peripheral Parenteral Solution Consumption and Growth Rate (2017-2022)
-
Figure Global by Nutritional Content Consumption and Growth Rate (2017-2022)
-
Figure Global Amino Acid Solution Consumption and Growth Rate (2017-2022)
-
Figure Global Carbohydrates Consumption and Growth Rate (2017-2022)
-
Figure Global Vitamins & Minerals Consumption and Growth Rate (2017-2022)
-
Figure Global Parenteral Lipid Emulsion Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals & Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Ambulatory Consumption and Growth Rate (2017-2022)
-
Figure Global Homecare Consumption and Growth Rate (2017-2022)
-
Figure Global by Product Type Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Total Parenteral Solution Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Peripheral Parenteral Solution Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global by Nutritional Content Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Amino Acid Solution Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Carbohydrates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vitamins & Minerals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Parenteral Lipid Emulsion Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals & Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ambulatory Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Homecare Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Intravenous (IV) Solution Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Intravenous (IV) Solution Export by Region (Top 5 Countries) (2017-2028)
-
Table Fresenius Kabi (Foundation Year, Company Profile and etc.)
-
Table Fresenius Kabi Intravenous (IV) Solution Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fresenius Kabi Intravenous (IV) Solution Product and Service
-
Table Terumo Medical Corporation (Foundation Year, Company Profile and etc.)
-
Table Terumo Medical Corporation Intravenous (IV) Solution Sales, Price, Value and Gross Profit (2017-2022)
-
Table Terumo Medical Corporation Intravenous (IV) Solution Product and Service
-
Table Grifols (Foundation Year, Company Profile and etc.)
-
Table Grifols Intravenous (IV) Solution Sales, Price, Value and Gross Profit (2017-2022)
-
Table Grifols Intravenous (IV) Solution Product and Service
-
Table Amanta Healthcare (Foundation Year, Company Profile and etc.)
-
Table Amanta Healthcare Intravenous (IV) Solution Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amanta Healthcare Intravenous (IV) Solution Product and Service
-
Table B Braun Melsungen (Foundation Year, Company Profile and etc.)
-
Table B Braun Melsungen Intravenous (IV) Solution Sales, Price, Value and Gross Profit (2017-2022)
-
Table B Braun Melsungen Intravenous (IV) Solution Product and Service
-
Table ICU Medical (Foundation Year, Company Profile and etc.)
-
Table ICU Medical Intravenous (IV) Solution Sales, Price, Value and Gross Profit (2017-2022)
-
Table ICU Medical Intravenous (IV) Solution Product and Service
-
Table Baxter (Foundation Year, Company Profile and etc.)
-
Table Baxter Intravenous (IV) Solution Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter Intravenous (IV) Solution Product and Service
-
